Author/Creator: Gupta, Rishab A. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Gupta, Rishab A.

1. Clinical outcomes in high‐hypoglycaemia‐risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first‐generation basal insulin analogue in the United States : Results from the DELIVER High Risk real‐world study. Issue 1 (22nd November 2021)

Authors:: Sullivan, Sean D.; Freemantle, Nick; Gupta, Rishab A.; Wu, Jasmanda; Nicholls, Charlie J.; Westerbacka, Jukka; Bailey, Timothy S.
Journal:: Endocrinology, diabetes & metabolism
Issue:: Volume 5:Issue 1(2022)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study. Issue 9 (25th June 2018)

Authors:: Sullivan, Sean D.; Bailey, Timothy S.; Roussel, Ronan; Zhou, Fang Liz; Bosnyak, Zsolt; Preblick, Ronald; Westerbacka, Jukka; Gupta, Rishab A.; Blonde, Lawrence
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 20:Issue 9(2018)
Page Start:: 2148
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world study. Issue 9 (21st June 2019)

Authors:: Sullivan, Sean D.; Nicholls, Charlie J.; Gupta, Rishab A.; Menon, Arjun A.; Wu, Jasmanda; Westerbacka, Jukka; Bosnyak, Zsolt; Frias, Juan P.; Bailey, Timothy S.
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 21:Issue 9(2019)
Page Start:: 2123
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study. Issue 7 (5th April 2019)

Authors:: Bailey, Timothy S.; Zhou, Fang L.; Gupta, Rishab A.; Preblick, Ronald; Gupta, Vineet E.; Berhanu, Paulos; Blonde, Lawrence
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 21:Issue 7(2019)
Page Start:: 1596
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin. Issue 5 (24th January 2018)

Authors:: Zhou, Fang Liz; Ye, Fen; Berhanu, Paulos; Gupta, Vineet E.; Gupta, Rishab A.; Sung, Jennifer; Westerbacka, Jukka; Bailey, Timothy S.; Blonde, Lawrence
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 20:Issue 5(2018)
Page Start:: 1293
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3). Issue 11 (18th July 2019)

Authors:: Bailey, Timothy S.; Wu, Jasmanda; Zhou, Fang L.; Gupta, Rishab A.; Menon, Arjun A.; Berhanu, Paulos; Westerbacka, Jukka; Van Vleet, John; Blonde, Lawrence
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 21:Issue 11(2019)
Page Start:: 2384
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗